Members of the CD28 family (CD28 and ICOS) play key roles in regulating T cell activation in response to antigen. For this reason they are attractive targets of immunotherapy regimes which aim to either attenuate the T cell responses to prevent allergic reactions, rejection of transplanted tissue and autoimmune disease, or augment responses against poorly immunogenic tumor or viral antigens. CD28 and ICOS provide costimulatory signals that allow a T cell to secrete effector cytokines but only CD28 costimulation protects a cell from apoptosis and permits long-term expansion. While much is known about the effects of the CD28 family on T cell activation, considerably less is understood about the signaling pathways that control these diverse functional outcomes. For instance, several groups have observed that CD28 costimulation enhances the expression of Bcl-xL and IL-2 using distinct mechanisms but the pathways that lead to this distinct regulation are unknown. Our approach is to utilize the structural similarity of the CD28 family to create a series of loss of function (LOF) and gain of function (GOF) mutant that will allow us to probe the mechanisms by which CD28 and ICOS alter T cell activation in primary human T cells.
In Specific Aim 1 we will define the motifs responsible for the enhanced regulation of Bcl-xL and IL-2 and use these LOF and GOF mutants to characterize these distinct CD28 mediated signals.
Aim 2 will address the question of how many signaling motifs are operational within the ICOS cytoplasmic tail and define the pathways that are activated by these motifs. Finally, we will develop a cell based model to validate our finding using a cell based model that uses the natural ligands to activate the T cells and permits ligand/receptor movement with the respective cell membranes. The data generated from these studies will better define the relationship between antigen dependent and independent signals and enable new strategies to modulate T cell activation for therapeutic applications.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI057838-01A1
Application #
6823954
Study Section
Allergy and Immunology Study Section (ALY)
Program Officer
Nabavi, Nasrin N
Project Start
2004-05-04
Project End
2009-04-30
Budget Start
2004-05-04
Budget End
2005-04-30
Support Year
1
Fiscal Year
2004
Total Cost
$356,625
Indirect Cost
Name
University of Pennsylvania
Department
Pathology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Paulos, Chrystal M; Carpenito, Carmine; Plesa, Gabriela et al. (2010) The inducible costimulator (ICOS) is critical for the development of human T(H)17 cells. Sci Transl Med 2:55ra78
June, Carl H; Blazar, Bruce R; Riley, James L (2009) Engineering lymphocyte subsets: tools, trials and tribulations. Nat Rev Immunol 9:704-16
Milone, Michael C; Fish, Jonathan D; Carpenito, Carmine et al. (2009) Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo. Mol Ther 17:1453-64
Riley, James L (2009) PD-1 signaling in primary T cells. Immunol Rev 229:114-25
Riley, James L; June, Carl H; Blazar, Bruce R (2009) Human T regulatory cell therapy: take a billion or so and call me in the morning. Immunity 30:656-65
Basu, Samik; Golovina, Tatiana; Mikheeva, Tatiana et al. (2008) Cutting edge: Foxp3-mediated induction of pim 2 allows human T regulatory cells to preferentially expand in rapamycin. J Immunol 180:5794-8
Varela-Rohena, Angel; Carpenito, Carmine; Perez, Elena E et al. (2008) Genetic engineering of T cells for adoptive immunotherapy. Immunol Res 42:166-81
Golovina, Tatiana N; Mikheeva, Tatiana; Suhoski, Megan M et al. (2008) CD28 costimulation is essential for human T regulatory expansion and function. J Immunol 181:2855-68
Kawadler, Holli; Gantz, Mary A; Riley, James L et al. (2008) The paracaspase MALT1 controls caspase-8 activation during lymphocyte proliferation. Mol Cell 31:415-21
Hu, Shimin; Du, Ming-Qing; Park, Sun-Mi et al. (2006) cIAP2 is a ubiquitin protein ligase for BCL10 and is dysregulated in mucosa-associated lymphoid tissue lymphomas. J Clin Invest 116:174-81

Showing the most recent 10 out of 15 publications